Maryland HB 466: Prescription Drug Monitoring Program - Program Evaluation

Status: Approved by the Governor - Chapter 364 (as of 2019-04-30)

State: Maryland · Session: 2019 · Bill: HB 466

Subjects: Public Health, Administrative Agencies, Attorney General, Committees and Commissions, Communications, Data, Discipline, Disclosure, Drugs, Examinations, Federal Government, Health Care Facilities, Health Occupations, Interstate Affairs, Investigations and Inquiries, Law Enforcement, Legislative Services, Department of, Licenses, Medical Examiners, Medical Treatments, Patients, Penalties and Sentences, Physicians, Records, Reports, Rules and Regulations, Subpoenas, Sunset, Voting

Sponsors: Kerr, Bagnall, Barron, Bhandari, C. Watson, Cain, Carr, Charles, Chisholm, Cox, Cullison, Feldmark, Hill, Jalisi, Johnson, K. Young, Kelly, Kipke, Krebs, Krimm, Lafferty, Metzgar, Morgan, Pena-Melnyk, Pendergrass

View Maryland HB 466 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.